Disease Screening & Early Detection

At UniMedNTech, we are committed to making early detection accessible, affordable, and impactful. Our screening programmes focus on critical conditions such as Cancer, Tuberculosis, and Sickle Cell Disease, with particular emphasis on working women and younger populations. By delivering cost effective solutions, we empower communities to take proactive steps toward healthier futures.

Public Health Programme Facilitation

As a trusted partner to State and Central Governments, UniMedNTech has emerged as a leader in the deployment of large scale public health initiatives under the National Health Mission. Our expertise lies in designing, implementing, and monitoring screening programmes that drive measurable improvements in population health outcomes.

Corporate & Employee Screening Initiatives

We extend our services to the corporate sector by offering employee centric screening programmes. These initiatives include targeted screenings for employees and their female family members—mothers, wives, and sisters—recognising their invaluable contribution to society and ensuring timely diagnosis and pathways to treatment.

Strategic Consultancy & Liaison Services

Beyond healthcare, UniMedNTech provides specialised consultancy and liaison support to domestic and international corporations. Our advisory services span diverse sectors including healthcare, pharmaceuticals, medical education, agriculture, forestry, infrastructure, and power, enabling organisations to strategically expand and strengthen their presence in India.

Facilitation of Specialised Treatments

In the highly specialised domain of name patient medicines, UniMedNTech facilitates access to USFDA and European FDA approved therapies not yet authorised by the Drug Controller General of India (DCGI). These treatments—urgently required for conditions such as cancer, multiple sclerosis, chronic migraine, diabetes, HIV, and severe infections—are made available strictly in compliance with Government of India approvals, licenses, and certifications. By bridging regulatory gaps, we ensure that patients can access life saving therapies in small, approved quantities for personal use.